Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-76.53M
↓ 82% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-42.11M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-76.53M | -21.2% |
| 2024 | $-63.15M | -20.7% |
| 2023 | $-52.33M | -12.7% |
| 2022 | $-46.43M | -28.6% |
| 2021 | $-36.11M | -97.7% |
| 2020 | $-18.27M | -827.7% |
| 2019 | $-1.97M | - |